Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-03-15$56.46/sh−184$10,389→ 38,883 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 03/14/2024.